Showing results (241-250 of 261) with videos related to
Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research HospitalA W Walter, M L Hancock, C H Pui, et al.Archives of Surgery (Chicago, Ill. : 1960)|November 1, 1987
Challenges in the treatment of childhood fibromatosisB N Rao, M E Horowitz, D M Parham, et al.Cancer|September 26, 1997
Comparison of primary osteosarcoma of flat bones with secondary osteosarcoma of any siteC B Pratt, W H Meyer, B N Rao, et al.Lancet (London, England)|August 18, 1990
Myeloid neoplasia in children treated for solid tumoursC H Pui, M L Hancock, S C Raimondi, et al.Journal of Pediatric Hematology/Oncology|August 1, 1995
Ifosfamide/carboplatin/etoposide (ICE) for recurrent malignant solid tumors of childhood: a Pediatric Oncology Group Phase I/II studyF H Kung, S J Desai, J D Dickerman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Therapy for childhood soft-tissue sarcomas other than rhabdomyosarcoma: a review of 62 cases treated at a single institutionM E Horowitz, C B Pratt, B L Webber, et al.The New England Journal of Medicine|June 19, 1986
The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremityM P Link, A M Goorin, A W Miser, et al.Medical and Pediatric Oncology|February 25, 1998
A pilot study of vincristine, ifosfamide, and doxorubicin in the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomasA W Walter, P D Shearer, A S Pappo, et al.Seminars in Oncology|February 1, 1989
Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988C B Pratt, E C Douglass, E Etcubanas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapyW L Furman, D L Fairclough, R D Huhn, et al.Pageof 27